If true, these findings open opportunities for further research concerning glioma tumourigenesis, possible therapeutic effects of MAO-inhibitors, and the possible predictive value of MAO-A-genotype as a diagnostic marker in males. The gene discussed is MAOA; the disease is central nervous system cancer.